BIBLIOGRAPHIC RECORD

Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Ian B. Hickie; Allan H. Young; F. Markus Leweke
Source of metadata
Crossref
Year recorded
2023

Public identifiers and source

Open the source record

Reference

Ian B. Hickie; Allan H. Young; F. Markus Leweke. (2023). Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders? https://doi.org/10.1017/dep.2023.21

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-68bd4feeb66fc22cbec91431d8d55954/